Clinical Remission in Severe Asthma : A Pooled Post hoc Analysis of the Patient Journey with Benralizumab
| dc.contributor.author | Menzies-Gow, Andrew | |
| dc.contributor.author | Hoyte, Flavia L. | |
| dc.contributor.author | Price, David | |
| dc.contributor.author | Cohen, David | |
| dc.contributor.author | Barker, Peter | |
| dc.contributor.author | Kreindler, James | |
| dc.contributor.author | Jison, Maria | |
| dc.contributor.author | Brooks, Christopher L. | |
| dc.contributor.author | Papeleu, Peggy | |
| dc.contributor.author | Katial, Rohit | |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.date.accessioned | 2022-05-05T09:19:01Z | |
| dc.date.available | 2022-05-05T09:19:01Z | |
| dc.date.issued | 2022-05-01 | |
| dc.description | Funding This study, the Rapid Service Fee, and the Open Access Fee were funded by AstraZeneca (Gaithersburg, MD, USA). | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 20 | |
| dc.format.extent | 1454603 | |
| dc.identifier | 214150052 | |
| dc.identifier | 12da78b4-96d2-4771-ac5c-2ef3e3efba56 | |
| dc.identifier | 85126230183 | |
| dc.identifier | 35287231 | |
| dc.identifier.citation | Menzies-Gow, A, Hoyte, F L, Price, D, Cohen, D, Barker, P, Kreindler, J, Jison, M, Brooks, C L, Papeleu, P & Katial, R 2022, 'Clinical Remission in Severe Asthma : A Pooled Post hoc Analysis of the Patient Journey with Benralizumab ', Advances in Therapy, vol. 39, no. 5, pp. 2065–2084. https://doi.org/10.1007/s12325-022-02098-1 | en |
| dc.identifier.doi | 10.1007/s12325-022-02098-1 | |
| dc.identifier.iss | 5 | en |
| dc.identifier.issn | 0741-238X | |
| dc.identifier.uri | https://hdl.handle.net/2164/18523 | |
| dc.identifier.vol | 39 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Advances in Therapy | en |
| dc.subject | Benralizumab | en |
| dc.subject | Biologic therapies | en |
| dc.subject | Oral corticosteroids (OCS) | en |
| dc.subject | Precision medicine | en |
| dc.subject | Remission | en |
| dc.subject | Severe eosinophilic asthma | en |
| dc.subject | Super-response | en |
| dc.subject | Treat-to-target | en |
| dc.subject | R Medicine | en |
| dc.subject | Supplementary Information | en |
| dc.subject | Supplementary Data | en |
| dc.subject.lcc | R | en |
| dc.title | Clinical Remission in Severe Asthma : A Pooled Post hoc Analysis of the Patient Journey with Benralizumab | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Menzies_Gow_etal_AT_Clinical_Remission_In_VOR.pdf
- Size:
- 1.39 MB
- Format:
- Adobe Portable Document Format
